𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhanced mobilization of CD34+progenitor cells expressing cell adhesion molecules in patients with STEMI

✍ Scribed by Michael Brehm; Petra Ebner; Frauke Picard; Ryan Urbien; Gökmen Turan; Bodo-Eckehard Strauer

Publisher
Springer
Year
2009
Tongue
English
Weight
355 KB
Volume
98
Category
Article
ISSN
1861-0684

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive parameters for mobilized peri
Predictive parameters for mobilized peripheral blood CD34+ progenitor cell collection in patients with hematological malignancies
✍ D'Arena, Giovanni; Musto, Pellegrino; Di Mauro, Lazzaro; Cascavilla, Nicola; Iac 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

In order to investigate what is the best single parameter to predict the leukapheretic yield of circulating CD34+ progenitor cells, we retrospectively analyzed data from 68 patients with hematological malignancies who underwent mobilizing therapy. Three main parameters were monitored: total white bl

EXPRESSION OF THE CELL ADHESION MOLECULE
EXPRESSION OF THE CELL ADHESION MOLECULE E-CADHERIN BY THE HUMAN BONE MARROW STROMAL CELLS AND ITS PROBABLE ROLE IN CD34+STEM CELL ADHESION
✍ K.R. Turel; S.G.A. Rao 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Bone marrow stroma is the physical basis of the haematopoietic microenvironment and regulates several key features of stem cell proliferation and differentiation. It plays a crucial role in maintaining haematopoietic homeostasis. Earlier studies have shown that this is achieved through interactions

Tempo of hematologic recovery correlates
Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization
✍ Ocean Williams; Taner Demirer; Kathy Lilleby; C. Dean Buckner; W. I. Bensinger 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

This study was undertaken to evaluate the relationship between the time to recovery of peripheral blood counts and CD34+ cells in the peripheral blood (PB) and apheresis collections of patients undergoing intensive chemotherapy followed by rhG-CSF. Twenty-three patients with a median age of 42 years

Phase I study in melanoma patients of a
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells
✍ Andreas Mackensen; Birgit Herbst; Ji-Li Chen; Gabriele Köhler; Christoph Noppen; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 268 KB 👁 2 views

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that can be used for vaccination purposes, to induce a specific T-cell response in vivo against melanomaassociated antigens. We have shown that the sequential use of early-acting hematopoietic growth factors, stem cell factor, IL